TABLE OF CONTENTS

  1. Introduction
    • Definition of Transplant Diagnostics Market
    • Scope of the Report
  2. Methodology
    • Executive Summary
    • Market Overview
    • Market Definition and Segmentation
  3. Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
    • Porter's Five Forces Analysis
    • PESTEL Analysis
  4. Transplant Diagnostics Market, By Technology:
    • Molecular assay technologies
      • PCR-based molecular assays
      • Real-time PCR
      • Sequence-specific primer-PCR
      • Sequence-specific Oligonucleotide-PCR
      1. Other PCR-based molecular assays
    • Sequencing based molecular assays
      • Sanger sequencing
      • Next generation sequencing
      • Other sequencing based molecular assays
    • Non molecular assays technologies
  5. Transplant Diagnostics Market, By Product & Service:
    • Reagents & Consumables
    • Instruments
    • Software & Services
  6. Transplant Diagnostics Market, By Application:
    • Diagnostic application
      • Pre-transplantation Diagnostics
        • Infectious Disease testing
        • Histocompatibility testing
        • Blood profiling
      • Post -transplantation Diagnostics
    • Research applications
  7. Transplant Diagnostics Market, By transplant type:
    • Solid Organ Transplantation
      • Kidney transplantation
      • Liver transplantation
      • Heart transplantation
      • Lung transplantation
      • Pancrease transplantation
      • Other Organs transplantation
    • Stem Cell transplantation
    • Soft tissue transplantation
    • Bone marrow transplantation
  8. Transplant Diagnostics Market, By End User:
    • Hospitals and Transplant centers
    • Research &Academic Institutes
    • Independent reference laboratories
  9. Transplant Diagnostics Market, By Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • Saudi Arabia
      • United Arab Emirates
      • South Africa
      • Rest of Middle East & Africa
  10. Competitive Landscape
  11. Company Profiles
    • Hologic, Inc.
      • Company Overview
      • Product Portfolio and Description
      • Key Highlights
      • Financial Overview
    • Luminex Corporation
  12. Thermo Fisher Scientific
    • Qiagen Nv
    • Becton, Dickinson And Company
    • HistogeneticsLlc
    • Biomérieux Sa
    • Pacific Biosciences Of California, Inc.
    • Gendx
    • Bio-Rad Laboratories
    • Illumina, Inc.
    • Alphabiotech Limited
    • F. Hoffmann-La Roche Ltd.
    • Merck Kgaa
    • Omixon
    • Tbg Diagnostics Limited
    • Biofortuna
    • Bag Diagnostics Gmbh
    • Hansa Biopharma Ab
    • Caredx
    • Immucor, Inc.
    • Takara Bio Inc.
    • Inno-Train DiagnostikGmbh
  13. Conclusion and Future Outlook
  14. Appendix
    • Research Methodology
    • About the Pharmanucleus

15. Disclaimer



Why Choose Us

Inclusion of Pre-clinical Molecules

Other than an extensive coverage of clinical and commercial drugs, our reports also provide details about pre-clinical molecules!

Start-up
Profiling

One of our marquee services We profile relevant start-up companies in the market.

KOL
Insight's

Get access to reliable data our insights and analyses are backed by Key Opinion Leaders in the field.

Specialized in Healthcare

Our team comprises of industry specialists and research experts from life sciences area holding degree in Medicine, Doctor of Pharmacy, M.Sc. in Pharmacy, Pharma MBAs, and Biotechnology.